1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Cardiovascular Implants Market, by Type
6.1. Introduction
6.2. Cardiac Resynchronization Therapy Device
6.3. Coronary Stents
6.4. Heart Valves
6.5. Implantable Cardioverter Defibrillator
6.6. Implanted Cardiac Pacemakers
6.7. Peripheral Stents

7. Cardiovascular Implants Market, by End User
7.1. Introduction
7.2. Cardiac Care Centers
7.3. Hospitals
7.4. Specialty Clinics

8. California Cardiovascular Implants Market

9. Florida Cardiovascular Implants Market

10. Illinois Cardiovascular Implants Market

11. New York Cardiovascular Implants Market

12. Ohio Cardiovascular Implants Market

13. Pennsylvania Cardiovascular Implants Market

14. Texas Cardiovascular Implants Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Abbott Laboratories
16.2. AMG International
16.3. B. Braun Melsungen AG
16.4. BIOTRONIK
16.5. Boston Scientific Corporation
16.6. Edwards Lifesciences
16.7. Fortimedix
16.8. Johnson & Johnson
16.9. Medtronic plc
16.10. Neovasc Inc.
16.11. On-X Life Technologies Inc.
16.12. Proxy Biomedical Limited
16.13. REVA Medical Inc
16.14. The Sorin Group
16.15. W.L. Gore & Associates Inc

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2027
FIGURE 6. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 19. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END USER, 2027
FIGURE 21. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: FPNV POSITIONING MATRIX
FIGURE 28. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 29. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CARDIOVASCULAR IMPLANTS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: SCORES
TABLE 15. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: BUSINESS STRATEGY
TABLE 16. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: PRODUCT SATISFACTION
TABLE 17. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: RANKING
TABLE 18. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 19. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: MERGER & ACQUISITION
TABLE 20. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 21. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 22. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: INVESTMENT & FUNDING
TABLE 23. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 24. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AMG International
B. Braun Melsungen AG
BIOTRONIK
Boston Scientific Corporation
Edwards Lifesciences
Fortimedix
Johnson & Johnson
Medtronic plc
Neovasc Inc.
On-X Life Technologies Inc.
Proxy Biomedical Limited
REVA Medical Inc
The Sorin Group
W.L. Gore & Associates Inc